Genmab — Maj 2020

[E_L]

(maybe i should also add that my pattern would then project a gap up open on Tuesday at 2175ish )

[Helge_LarsenPI-redaktør]

Fra below 2000 from yesterday.

[Michael_Almskov]

Amerikansk biotekselskab får adgang til Genmabs medicinplatform

Genmab og det amerikanske biotekselskab Tavotek har indgået en forskningsaftale, der skal kombinere de to selskabers platforme til at identificere nye lægemiddelkandidater mod autoimmune og inflammatoriske sygdomme.

(medwatch.dk)

[Michael_Almskov]

nyt samarbejde med Tavotek

[E_L]

https://twitter.com/Genmab/status/1265991419895971840

[Skyggen]

Nice on E L Thanks

[bibob]

16 / 3 -2020 var Genmab i 1149,5. Næsten 1000 point på 2,5 md. Ikk så ringe endda.

[E_L]

and then Jan says in the Q&A "Jan Van de Winkel More to come from Genmab in the coming time!":-D

[E_L]

US breaking their ATH from Tuesday
now

[bikube]

bibob - det er slutkursen fra d.16/3, du refererer til - laveste kurs den dag var 1082,50.

[Legolas23]

Ærgerlig lukkehandel

[Bisseministeren]

Svært at klage med en stigning på 4,5%

[Solsen]

89 point er ikke noget man ærgrer sig over

[gdn55]

Indtil videre et plus i denne uge på 45,00,
det er ok i min lille verden

[E_L]

they are really keen to promote their epco poster lol https://twitter.com/Genmab/status/1266021659988963328

[GeorgeBest]

E L - have you found a possibility for private investors to follow the presentation? Or should we as previous years wait for tweets from the oncologists?

[bibob]

Bikube . Ja det var.

[E_L]

i think the only way would be to buy a ticket to the conference... and i am not even sure what to expect from a 'virtual poster discussion'? it is not an oral
presentation

[GeorgeBest]

No they are apparantly prerecorded. There cant be much discussion...

[mobbyduck1]

Genmab Announces Positive Topline Results in Phase III ANDROMEDA Study of Daratumumab in Light-chain (AL) Amyloidosis